BMRA Relative Valuation
BMRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BMRA is overvalued; if below, it's undervalued.
Historical Valuation
Biomerica Inc (BMRA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of 11.14. The fair price of Biomerica Inc (BMRA) is between 11.75 to 49.45 according to relative valuation methord. Compared to the current price of 2.78 USD , Biomerica Inc is Undervalued By 76.35%.
Relative Value
Fair Zone
11.75-49.45
Current Price：2.78
76.35%
Undervalued
0.81
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Biomerica Inc. (BMRA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.89. The thresholds are as follows: Strongly Undervalued below -4.53, Undervalued between -4.53 and -1.82, Fairly Valued between 3.60 and -1.82, Overvalued between 3.60 and 6.31, and Strongly Overvalued above 6.31. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.95
EV/EBIT
Biomerica Inc. (BMRA) has a current EV/EBIT of 0.95. The 5-year average EV/EBIT is 11.74. The thresholds are as follows: Strongly Undervalued below -57.52, Undervalued between -57.52 and -22.89, Fairly Valued between 46.36 and -22.89, Overvalued between 46.36 and 80.99, and Strongly Overvalued above 80.99. The current Forward EV/EBIT of 0.95 falls within the Historic Trend Line -Fairly Valued range.
0.28
PS
Biomerica Inc. (BMRA) has a current PS of 0.28. The 5-year average PS is 2.49. The thresholds are as follows: Strongly Undervalued below -2.27, Undervalued between -2.27 and 0.11, Fairly Valued between 4.86 and 0.11, Overvalued between 4.86 and 7.24, and Strongly Overvalued above 7.24. The current Forward PS of 0.28 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Biomerica Inc. (BMRA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.86. The thresholds are as follows: Strongly Undervalued below -13.17, Undervalued between -13.17 and -6.15, Fairly Valued between 7.88 and -6.15, Overvalued between 7.88 and 14.90, and Strongly Overvalued above 14.90. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Biomerica Inc. (BMRA) has a current P/FCF of 0.00. The 5-year average P/FCF is 5.27. The thresholds are as follows: Strongly Undervalued below -25.91, Undervalued between -25.91 and -10.32, Fairly Valued between 20.87 and -10.32, Overvalued between 20.87 and 36.46, and Strongly Overvalued above 36.46. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Biomerica Inc (BMRA) has a current Price-to-Book (P/B) ratio of 1.38. Compared to its 3-year average P/B ratio of 1.98 , the current P/B ratio is approximately -30.24% higher. Relative to its 5-year average P/B ratio of 3.53, the current P/B ratio is about -60.82% higher. Biomerica Inc (BMRA) has a Forward Free Cash Flow (FCF) yield of approximately -37.07%. Compared to its 3-year average FCF yield of -46.71%, the current FCF yield is approximately -20.63% lower. Relative to its 5-year average FCF yield of -30.05% , the current FCF yield is about 23.35% lower.
1.38
P/B
Median3y
1.98
Median5y
3.53
-37.07
FCF Yield
Median3y
-46.71
Median5y
-30.05
Competitors Valuation Multiple
The average P/S ratio for BMRA's competitors is 4.78, providing a benchmark for relative valuation. Biomerica Inc Corp (BMRA) exhibits a P/S ratio of 0.28, which is -94.13% above the industry average. Given its robust revenue growth of -23.63%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BMRA decreased by 31.17% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.87 to -1.68.
The secondary factor is the Revenue Growth, contributed -23.63%to the performance.
Overall, the performance of BMRA in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
Frequently Asked Questions
Is Biomerica Inc (BMRA) currently overvalued or undervalued?
Biomerica Inc (BMRA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of 11.14. The fair price of Biomerica Inc (BMRA) is between 11.75 to 49.45 according to relative valuation methord. Compared to the current price of 2.78 USD , Biomerica Inc is Undervalued By 76.35% .
What is Biomerica Inc (BMRA) fair value?
BMRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Biomerica Inc (BMRA) is between 11.75 to 49.45 according to relative valuation methord.
How does BMRA's valuation metrics compare to the industry average?
The average P/S ratio for BMRA's competitors is 4.78, providing a benchmark for relative valuation. Biomerica Inc Corp (BMRA) exhibits a P/S ratio of 0.28, which is -94.13% above the industry average. Given its robust revenue growth of -23.63%, this premium appears unsustainable.
What is the current P/B ratio for Biomerica Inc (BMRA) as of Jan 08 2026?
As of Jan 08 2026, Biomerica Inc (BMRA) has a P/B ratio of 1.38. This indicates that the market values BMRA at 1.38 times its book value.
What is the current FCF Yield for Biomerica Inc (BMRA) as of Jan 08 2026?
As of Jan 08 2026, Biomerica Inc (BMRA) has a FCF Yield of -37.07%. This means that for every dollar of Biomerica Inc’s market capitalization, the company generates -37.07 cents in free cash flow.
What is the current Forward P/E ratio for Biomerica Inc (BMRA) as of Jan 08 2026?
As of Jan 08 2026, Biomerica Inc (BMRA) has a Forward P/E ratio of 0.81. This means the market is willing to pay $0.81 for every dollar of Biomerica Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Biomerica Inc (BMRA) as of Jan 08 2026?
As of Jan 08 2026, Biomerica Inc (BMRA) has a Forward P/S ratio of 0.28. This means the market is valuing BMRA at $0.28 for every dollar of expected revenue over the next 12 months.